BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 10562557)

  • 1. SUMO-1 modification activates the transcriptional response of p53.
    Rodriguez MS; Desterro JM; Lain S; Midgley CA; Lane DP; Hay RT
    EMBO J; 1999 Nov; 18(22):6455-61. PubMed ID: 10562557
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of p53 by conjugation to the ubiquitin-like protein SUMO-1.
    Gostissa M; Hengstermann A; Fogal V; Sandy P; Schwarz SE; Scheffner M; Del Sal G
    EMBO J; 1999 Nov; 18(22):6462-71. PubMed ID: 10562558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Members of the PIAS family act as SUMO ligases for c-Jun and p53 and repress p53 activity.
    Schmidt D; Müller S
    Proc Natl Acad Sci U S A; 2002 Mar; 99(5):2872-7. PubMed ID: 11867732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Involvement of PIAS1 in the sumoylation of tumor suppressor p53.
    Kahyo T; Nishida T; Yasuda H
    Mol Cell; 2001 Sep; 8(3):713-8. PubMed ID: 11583632
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional analysis and intracellular localization of p53 modified by SUMO-1.
    Kwek SS; Derry J; Tyner AL; Shen Z; Gudkov AV
    Oncogene; 2001 May; 20(20):2587-99. PubMed ID: 11420669
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The small ubiquitin-like modifier-1 (SUMO-1) consensus sequence mediates Ubc9 binding and is essential for SUMO-1 modification.
    Sampson DA; Wang M; Matunis MJ
    J Biol Chem; 2001 Jun; 276(24):21664-9. PubMed ID: 11259410
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of an N-terminal site of Ubc9 in SUMO-1, -2, and -3 binding and conjugation.
    Tatham MH; Kim S; Yu B; Jaffray E; Song J; Zheng J; Rodriguez MS; Hay RT; Chen Y
    Biochemistry; 2003 Aug; 42(33):9959-69. PubMed ID: 12924945
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Mdm-2 amino terminus is required for Mdm2 binding and SUMO-1 conjugation by the E2 SUMO-1 conjugating enzyme Ubc9.
    Buschmann T; Lerner D; Lee CG; Ronai Z
    J Biol Chem; 2001 Nov; 276(44):40389-95. PubMed ID: 11384992
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MDM2 promotes SUMO-2/3 modification of p53 to modulate transcriptional activity.
    Stindt MH; Carter S; Vigneron AM; Ryan KM; Vousden KH
    Cell Cycle; 2011 Sep; 10(18):3176-88. PubMed ID: 21900752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of a substrate recognition site on Ubc9.
    Lin D; Tatham MH; Yu B; Kim S; Hay RT; Chen Y
    J Biol Chem; 2002 Jun; 277(24):21740-8. PubMed ID: 11877416
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of Ubc9, an E2 ligase for SUMO conjugation, with p53 is regulated by phosphorylation of p53.
    Lin JY; Ohshima T; Shimotohno K
    FEBS Lett; 2004 Aug; 573(1-3):15-8. PubMed ID: 15327968
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Covalent modification of the androgen receptor by small ubiquitin-like modifier 1 (SUMO-1).
    Poukka H; Karvonen U; Janne OA; Palvimo JJ
    Proc Natl Acad Sci U S A; 2000 Dec; 97(26):14145-50. PubMed ID: 11121022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Covalent modification of p73alpha by SUMO-1. Two-hybrid screening with p73 identifies novel SUMO-1-interacting proteins and a SUMO-1 interaction motif.
    Minty A; Dumont X; Kaghad M; Caput D
    J Biol Chem; 2000 Nov; 275(46):36316-23. PubMed ID: 10961991
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of p53 activity in nuclear bodies by a specific PML isoform.
    Fogal V; Gostissa M; Sandy P; Zacchi P; Sternsdorf T; Jensen K; Pandolfi PP; Will H; Schneider C; Del Sal G
    EMBO J; 2000 Nov; 19(22):6185-95. PubMed ID: 11080164
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SUMO-1 conjugation in vivo requires both a consensus modification motif and nuclear targeting.
    Rodriguez MS; Dargemont C; Hay RT
    J Biol Chem; 2001 Apr; 276(16):12654-9. PubMed ID: 11124955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ubch9 conjugates SUMO but not ubiquitin.
    Desterro JM; Thomson J; Hay RT
    FEBS Lett; 1997 Nov; 417(3):297-300. PubMed ID: 9409737
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure of ubiquitin-conjugating enzyme 9 displays significant differences with other ubiquitin-conjugating enzymes which may reflect its specificity for sumo rather than ubiquitin.
    Giraud MF; Desterro JM; Naismith JH
    Acta Crystallogr D Biol Crystallogr; 1998 Sep; 54(Pt 5):891-8. PubMed ID: 9757105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polyubiquitination of p53 by a ubiquitin ligase activity of p300.
    Grossman SR; Deato ME; Brignone C; Chan HM; Kung AL; Tagami H; Nakatani Y; Livingston DM
    Science; 2003 Apr; 300(5617):342-4. PubMed ID: 12690203
    [TBL] [Abstract][Full Text] [Related]  

  • 19. P14ARF promotes accumulation of SUMO-1 conjugated (H)Mdm2.
    Xirodimas DP; Chisholm J; Desterro JM; Lane DP; Hay RT
    FEBS Lett; 2002 Sep; 528(1-3):207-11. PubMed ID: 12297306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The ubiquitin-like proteins SMT3 and SUMO-1 are conjugated by the UBC9 E2 enzyme.
    Schwarz SE; Matuschewski K; Liakopoulos D; Scheffner M; Jentsch S
    Proc Natl Acad Sci U S A; 1998 Jan; 95(2):560-4. PubMed ID: 9435231
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.